D Collen
- Hematology top 0.02%
- Blood Coagulation and Thrombosis Mechanisms 185
- Platelet Disorders and Treatments 49
- Cancer Research top 0.02%
- Protease and Inhibitor Mechanisms 251
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management 27
- Immunology and Allergy top 0.1%
- Cell Adhesion Molecules Research 27
-
- Acute Myocardial Infarction Research 38
-
- Blood properties and coagulation 127
-
- Enzyme Production and Characterization 65
- Co-authors
- H.R. LijnenPeter CarmelietMarc HoylaertsD.C. RijkenHR LijnenHerman K. GoldF De CockB. Van Hoef
- Partner nations
- BelgiumUnited StatesJapan
In The Last Decade
D Collen
428 papers receiving 26.9k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Hematology 10.7k
- Cancer Research 11.8k
- Internal Medicine 2.7k
- Immunology and Allergy 2.1k
- Cardiology and Cardiovascular Medicine 5.4k
Countries citing papers authored by D Collen
This map shows the geographic impact of D Collen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Collen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Collen more than expected).
Fields of papers citing papers by D Collen
This network shows the impact of papers produced by D Collen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Collen. The network helps show where D Collen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D Collen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 6 | |
| 2 | 2003 | 256 | |
| 3 | 2002 | 17 | |
| 4 | Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation | 1999 | 1 |
| 5 | Human-like HDL -in vivo- reduces oxidative stress, Ca2+ transients, adhesion molecule expression and macrophage homing in apoE deficient mice | 1999 | 3 |
| 6 | Plasminogen activator (PA) and matrix metalloproteinase (MMP) system function after vascular injury in mice with targeted inactivation of fibrinolytic genes | 1997 | 1 |
| 7 | Reperfusion in acute myocardial infarction : International Society and Federation of Cardiology and World Health Organization Task Forece on Myocardial Reperfusion | 1994 | 7 |
| 8 | Reperfusion in acute myocardial infarction | 1994 | 6 |
| 9 | 1994 | 7 | |
| 10 | Coronary thrombolysis in perspective : principles underlying conjunctive and adjunctive therapy | 1993 | 5 |
| 11 | Molecular conversions of recombinant staphylokinase in purified systems and in human plasma during plasminogen activation | 1993 | 1 |
| 12 | Effects of fibrin-targeting and clearance rate on the thrombolytic potency of chimeric plasminogen activators consisting of a single-chain Fv fragment derived from a fibrin-specific antibody and single-chain u-PA (scu-PA) | 1992 | 3 |
| 13 | The role of the active center and lysine binding sites in plasmin-induced platelet activation | 1990 | 4 |
| 14 | Covalent interaction in the tpa-plasminogen activator inhibitor-1 (pai-1) complex is required for its dissociation from endothelial-cells | 1989 | 1 |
| 15 | BIOCHEMICAL AND BIOLOGICAL CHARACTERIZATION OF A NOVEL LOW-MOLECULAR-WEIGHT FORM OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) | 1986 | 1 |
| 16 | PRO-UROKINASE - KINETICS AND MECHANISM OF ACTION | 1985 | 6 |
| 17 | 1985 | 262 | |
| 18 | MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE FIBRIN-BINDING SITE OR THE ACTIVE-SITE OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) | 1985 | 3 |
| 19 | PURIFICATION AND CHARACTERIZATION OF PRO-UROKINASE FROM HUMAN-URINE AND CONDITIONED CELL-CULTURE MEDIA | 1985 | 9 |
| 20 | NEUTRALIZATION OF HEPARIN ACTIVITY BY BINDING TO HISTIDINE-RICH GLYCOPROTEIN IN PURIFIED SYSTEMS AND IN HUMAN-PLASMA | 1983 | 8 |
About D Collen
D Collen is a scholar working on Hematology, Cancer Research and Biotechnology, having authored 435 papers that have together received 28.7k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (251 papers), Blood Coagulation and Thrombosis Mechanisms (185 papers), Blood properties and coagulation (127 papers), Enzyme Production and Characterization (65 papers), Platelet Disorders and Treatments (49 papers), Acute Myocardial Infarction Research (38 papers), Venous Thromboembolism Diagnosis and Management (27 papers) and Cell Adhesion Molecules Research (27 papers). The work is most often cited by research in Hematology (10.7k citations), Cancer Research (11.8k citations) and Internal Medicine (2.7k citations). D Collen has collaborated with scholars based in Belgium, United States and Japan. Frequent co-authors include H.R. Lijnen, Peter Carmeliet, H.R. Lijnen, Marc Hoylaerts, D.C. Rijken, HR Lijnen, Herman K. Gold, F De Cock, B. Van Hoef and Robert C. Leinbach. Their work appears in journals such as Thrombosis and Haemostasis, Blood, Circulation, Journal of Biological Chemistry and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.